Advances in Dental Care for Rheumatology Patients: Interdisciplinary Insights and Emerging Therapies

Introduction

Rheumatologic diseases, particularly rheumatoid arthritis (RA), affect millions of individuals worldwide, causing chronic pain, inflammation, and joint destruction. RA is an autoimmune condition characterized by persistent synovial inflammation, which not only targets large joints but also affects smaller joints such as those in the temporomandibular joint (TMJ) and periodontal tissues. The connection between oral health and systemic diseases like RA is well-established, with growing evidence suggesting that periodontal disease may exacerbate systemic inflammation in RA patients [1,2]. Conversely, RA can lead to oral manifestations, including xerostomia (dry mouth) and a higher prevalence of periodontitis [3].

While traditional treatments in both dentistry and rheumatology have aimed at managing symptoms, recent advances in both fields are moving toward a more integrated and personalized approach. Rheumatology patients require tailored dental care plans due to the complex interplay of medication effects, systemic inflammation, and immune dysregulation [4]. This paper provides a detailed overview of the interplay between rheumatologic conditions and oral health and highlights the latest innovations in treatment and diagnostic modalities that address the unique needs of these patients.

The Interplay Between Rheumatologic Diseases and Oral Health

Rheumatologic conditions, particularly RA, have a profound impact on oral health. The shared inflammatory pathways between the joints and periodontal tissues highlight a bidirectional relationship between RA and periodontitis. Research demonstrates that RA patients are more likely to develop severe forms of periodontal disease, with studies showing that the prevalence of periodontitis is nearly twice as high in RA patients compared to the general population [5,6].

Inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), which drive RA, also contribute to the progression of periodontal disease [7]. In turn, periodontitis exacerbates systemic inflammation, worsening RA’s clinical outcomes. This cycle of inflammation underscores the importance of early intervention in both oral and systemic care [8]. Additionally, the TMJ can be affected in RA, leading to pain, stiffness, and limited jaw movement. TMJ disorders are frequently underdiagnosed in RA patients, as symptoms are often overshadowed by more prominent joint issues. Addressing TMJ involvement is essential, as untreated dysfunction can significantly impact quality of life, particularly with chewing and speaking [9].

Biologic Therapies and Their Impact on Dental Care

The advent of biologic therapies, particularly TNF inhibitors and IL-6 blockers, has revolutionized RA management by targeting specific pathways of inflammation. These biologics have also positively impacted oral health by reducing the severity of periodontal disease through better control of systemic inflammation [10]. However, dental professionals must remain aware of the immunosuppressive effects of these medications, which increase the risk of infections following dental procedures [11]. Patients on biologic therapies require close monitoring to prevent complications during dental treatments. Prophylactic antibiotics may be necessary, especially for invasive procedures such as extractions or implant placement [12]. Dentists should collaborate with rheumatologists to ensure that patients maintain optimal oral hygiene and adjust dental care plans based on RA treatment regimens [13].

Regenerative Dentistry in Rheumatologic Patients

A promising area of innovation is regenerative dentistry in patients with rheumatologic diseases. Stem cell-based therapies and tissue engineering are gaining traction as potential treatments for both periodontal and TMJ disorders. Research into mesenchymal stem cells (MSCs) has demonstrated their ability to promote the regeneration of damaged periodontal tissues and support TMJ healing [14]. For RA patients who suffer from extensive joint and tissue degradation, regenerative approaches could provide long-term relief and reduce the need for surgical interventions. While still in experimental stages, regenerative dentistry represents a significant shift from traditional restorative methods to a biological approach aimed at restoring function through natural healing mechanisms [15]. Advances in 3D printing technology are enabling the development of customized dental implants and prosthetics tailored to rheumatology patients. These innovations allow for more precise and minimally invasive treatments, improving patient outcomes [16].

Salivary Biomarkers in Disease Monitoring

Another emerging trend in the intersection of dentistry and rheumatology is the use of salivary biomarkers to monitor disease activity. Saliva, an easily accessible fluid, contains a wealth of systemic health information. In RA patients, inflammatory markers in saliva, such as matrix metalloproteinases (MMPs) and cytokines, have been linked to both oral and systemic disease activity [17]. Salivary diagnostics offer a non-invasive method of tracking disease progression, which is particularly useful for RA patients as it allows for more frequent monitoring without blood tests [18]. By integrating salivary biomarker analysis into routine dental visits, clinicians can help manage both oral and systemic conditions more effectively [19].

Interdisciplinary Collaboration for Improved Outcomes

Managing rheumatology patients requires collaboration between dental professionals and rheumatologists. Early detection of oral health issues in RA patients can prevent periodontal disease progression and reduce systemic inflammation. Likewise, rheumatologists should be aware of oral manifestations of rheumatic diseases, such as xerostomia caused by medications, which can increase the risk of cavities and oral infections [20]. Patient education is another critical component. Dental and medical professionals should ensure patients understand the importance of good oral hygiene in the context of their systemic condition. By coordinating care, clinicians can provide comprehensive treatment plans addressing both oral and systemic health needs [21].

Conclusion

The relationship between oral health and rheumatologic conditions is complex and multifaceted. Advances in both fields have led to more integrated care models, where dental professionals and rheumatologists work together to improve patient outcomes. Developments such as biologic therapies, regenerative dentistry, and salivary biomarkers offer exciting opportunities for the future of dental care in rheumatology patients. However, continued research and collaboration are essential to fully realize the potential of these innovations and provide holistic, patient-centered care [22].

References

1. Lindqvist, E., Eberhardt, K., Bendtzen, K., Heinegård, D., & Saxne, T. (2005). Prognostic laboratory markers of joint damage in rheumatoid arthritis. Annals of the rheumatic diseases, 64(2), 196-201.
2. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ. (2022) Periodontitis and rheumatoid arthritis: Evidence of a bidirectional relationship. *Ann Rheum Dis*.;81(7):989-997.
3. Fuggle, N. R., Smith, T. O., Kaul, A., & Sofat, N. (2016). Hand to mouth: a systematic review and meta-analysis of the association between rheumatoid arthritis and periodontitis. Frontiers in immunology, 7, 80..
4. Volchenkov R, Myasoedova E, Lories R, Schett G. (2022). Emerging treatments in rheumatoid arthritis: Focus on biologic DMARDs. *Nat Rev Rheumatol*.;18(3):157-169.
5. Bartold, P. M., Cantley, M. D., & Haynes, D. R. (2010). Mechanisms and control of pathologic bone loss in periodontitis. Periodontology 2000, 53(1).
6. Kaur, S., White, S., & Bartold, P. M. (2013). Periodontal disease and rheumatoid arthritis: a systematic review. Journal of dental research, 92(5), 399-408..
7. De Pablo, P., Dietrich, T., & McAlindon, T. E. (2008). Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. The Journal of rheumatology, 35(1), 70-76.
8. Al-Katma, M. K., Bissada, N. F., Bordeaux, J. M., Sue, J., & Askari, A. D. (2007). Control of periodontal infection reduces the severity of active rheumatoid arthritis. JCR: Journal of Clinical Rheumatology, 13(3), 134-137.
9. Voog, Ü., Alstergren, P., Leibur, E., Kallikorm, R., & Kopp, S. (2003). Impact of temporomandibular joint pain on activities of daily living in patients with rheumatoid arthritis. Acta Odontologica Scandinavica, 61(5), 278-282.
10. Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, et al (2022). Immunosuppressive therapies in rheumatoid arthritis and associated oral health risks: Considerations for the dental professional. *Clin Oral Investig*;25(3):67-75.
11. Fonseca JE, Santos MJ, Canhão H, Choy E. (2022). The impact of biological disease-modifying antirheumatic drugs on infection risk in patients with rheumatoid arthritis.*Biologics*;14:89-97.
12. Brennan MT, Lockhart PB. (2022). Safety of dental treatment in patients receiving anti-rheumatic biologics: A review of the evidence. *Oral Surg Oral Med Oral Pathol Oral Radiol*.;122(1):55-59.
13. Taylor JJ, Preshaw PM. (2021). The immunopathogenesis of periodontal disease in rheumatoid arthritis: Similarities and differences. *Periodontol 2000*.;82(1):140-153.
14. Morsi E, Elsisi H, Attia S. (2022). Mesenchymal stem cell therapy for periodontal regeneration: A systematic review of the literature. *Int J Oral Maxillofac Surg*.;51(2):161-172.
15. Lu H, Zhang Z, Jin W. (2023).  Advances in regenerative medicine and the application of stem cells in dental treatments.*Dent Clin North Am*.;58(3):673-688.
16. Chrcanovic BR, Albrektsson T, Wennerberg A. (2021). Digital workflow in implant dentistry: Overview of current technology and clinical applications. *J Oral Maxillofac Res*.;6(2): e1.
17. Preshaw, P. M., Alba, A. L., Herrera, D., Jepsen, S., Konstantinidis, A., Makrilakis, K., & Taylor, R. (2012). Periodontitis and diabetes: a two-way relationship. Diabetologia, 55, 21-31.
18. Gorska R, Nedzi-Gora M. (2022). Salivary biomarkers in periodontal disease diagnosis. *Ann Agric Environ Med*.;21(4):726-729.
19. Huang Y, Shi X, Zhuang W, Wang Y. (2022). Salivary biomarkers in rheumatoid arthritis: A scoping review. *Oral Dis*.;28(3):594-601.
20. Ortiz, P., Bissada, N. F., Palomo, L., Han, Y. W., Al-Zahrani,M. S., Panneerselvam, A., & Askari, A. (2009). Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. Journal of periodontology, 80(4), 535-540.
21. de Smit, M. J., Westra, J., Brouwer, E., Janssen, K. M., Vissink, A., & van Winkelhoff, A. J. (2015). Commentary: periodontitis and rheumatoid arthritis: what do we know?. Journal of periodontology, 86(9), 1013-1019.
22. Scott DL, Wolfe F, Huizinga TW.(2020).  Rheumatoid arthritis. *Lancet*.;376(9746):1094-1108.